相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Teaching old receptors new tricks: biasing seven-transmembrane receptors
Sudarshan Rajagopal et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
Shucheng Yin et al.
NEURO-ONCOLOGY (2010)
Aberrant intracellular IGF-1R β-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation
Natalia Natalishvili et al.
EXPERIMENTAL CELL RESEARCH (2009)
The insulin receptor substrate-1: A biomarker for cancer?
Renato Baserga
EXPERIMENTAL CELL RESEARCH (2009)
The Human Antimicrobial Peptide LL-37 Suppresses Apoptosis in Keratinocytes
Clara I. Chamorro et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
Seth B. Coffelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
Guenther Weber et al.
BREAST CANCER RESEARCH (2009)
Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth
Maria Toernkvist et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis
Bita Sehat et al.
CANCER RESEARCH (2008)
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells
Judith von Haussen et al.
LUNG CANCER (2008)
Microbial Patterns Signaling via Toll-Like Receptors 2 and 5 Contribute to Epithelial Repair, Growth and Survival
Renat Shaykhiev et al.
PLOS ONE (2008)
Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion
Seth B. Coffelt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin
Radu Vasilcanu et al.
MOLECULAR PHARMACOLOGY (2008)
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
David R. Clemmons
NATURE REVIEWS DRUG DISCOVERY (2007)
β-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling
Anton Razuvaev et al.
JOURNAL OF VASCULAR SURGERY (2007)
β-Arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression
Leonard Girnita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Receptor tyrosine kinases: mechanisms of activation and signaling
Stevan R. Hubbard et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Antimicrobial peptides: natural effectors of the innate immune system
Katherine Radek et al.
SEMINARS IN IMMUNOPATHOLOGY (2007)
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system
Peter G. Barlow et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Jamie S. Mader et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
The insulin-like growth factor-1 receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells
A Girnita et al.
CLINICAL CANCER RESEARCH (2006)
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
E Menu et al.
BLOOD (2006)
Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37
S Tokumaru et al.
JOURNAL OF IMMUNOLOGY (2005)
The insulin-like growth factor-1 receptor as a target for cancer therapy
R Baserga
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells:: A novel therapeutic approach
E Ulfarsson et al.
CLINICAL CANCER RESEARCH (2005)
β-arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase
L Girnita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Role of insulin-like growth factor 1 receptor signalling in cancer
O Larsson et al.
BRITISH JOURNAL OF CANCER (2005)
Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
JD Heilborn et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
A Elssner et al.
JOURNAL OF IMMUNOLOGY (2004)
Cathelicidins, multifunctional peptides of the innate immunity
M Zanetti
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor
GS Tjabringa et al.
JOURNAL OF IMMUNOLOGY (2003)
Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor
L Girnita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The insulin-like growth factor system and cancer
D LeRoith et al.
CANCER LETTERS (2003)
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
R Koczulla et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium
JD Heilborn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference
S Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
The contradictions of the insulin-like growth factor 1 receptor
R Baserga
ONCOGENE (2000)
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
D Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Structure and function of the type 1 insulin-like growth factor receptor
TE Adams et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases
M Dews et al.
ENDOCRINOLOGY (2000)
分享论文
